Artikel: An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen
New biotechnology. 2022 Aug. 07,
2022
Abstract: Developing affordable and easily manufactured SARS-CoV-2 vaccines will be essential to achieve worldwide vaccine coverage and long-term control of the COVID-19 pandemic. Here the development is reported of a vaccine based on the SARS-CoV-2 receptor- ... ...
| Abstract | Developing affordable and easily manufactured SARS-CoV-2 vaccines will be essential to achieve worldwide vaccine coverage and long-term control of the COVID-19 pandemic. Here the development is reported of a vaccine based on the SARS-CoV-2 receptor-binding domain (RBD), produced in the yeast Pichia pastoris. The RBD was modified by adding flexible N- and C-terminal amino acid extensions that modulate protein/protein interactions and facilitate protein purification. A fed-batch methanol fermentation with a yeast extract-based culture medium in a 50L fermenter and an immobilized metal ion affinity chromatography-based downstream purification process yielded 30-40mg/L of RBD. Correct folding of the purified protein was demonstrated by mass spectrometry, circular dichroism, and determinations of binding affinity to the angiotensin-converting enzyme 2 (ACE2) receptor. The RBD antigen also exhibited high reactivity with sera from convalescent individuals and Pfizer-BioNTech or Sputnik V vaccinees. Immunization of mice and non-human primates with 50µg of the recombinant RBD adjuvanted with alum induced high levels of binding antibodies as assessed by ELISA with RBD produced in HEK293T cells, and which inhibited RBD binding to ACE2 and neutralized infection of VeroE6 cells by SARS-CoV-2. Additionally, the RBD protein stimulated IFNγ, IL-2, IL-6, IL-4 and TNFα secretion in splenocytes and lung CD3⁺-enriched cells of immunized mice. The data suggest that the RBD recombinant protein produced in yeast P. pastoris is suitable as a vaccine candidate against COVID-19. |
|---|---|
| Schlagwörter | COVID-19 infection ; Komagataella pastoris ; Severe acute respiratory syndrome coronavirus 2 ; alum ; amino acids ; antigens ; biotechnology ; circular dichroism spectroscopy ; culture media ; fermentation ; fermenters ; immunization ; interleukin-2 ; interleukin-4 ; interleukin-6 ; lungs ; mass spectrometry ; methanol ; neutralization ; peptidyl-dipeptidase A ; purification methods ; recombinant proteins ; secretion ; splenocytes ; vaccines ; yeasts |
| Sprache | Englisch |
| Erscheinungsverlauf | 2022-0807 |
| Erscheinungsort | Elsevier B.V. |
| Dokumenttyp | Artikel |
| Anmerkung | Pre-press version |
| ZDB-ID | 2400836-9 |
| ISSN | 1876-4347 ; 1871-6784 |
| ISSN (online) | 1876-4347 |
| ISSN | 1871-6784 |
| DOI | 10.1016/j.nbt.2022.08.002 |
| Datenquelle | NAL Katalog (AGRICOLA) |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.